Comment
2024-04-05
Comment on Pharma Equity Group’s Positive Final Results From the Phase II Trial of the Drug Candidate RNX-051
Equity research report
2024-03-27
Movinn Q4-23
2024-03-22
Comment on Movinn’s Annual Report
Pharma Equity Group Q4-23
2023-12-14
Comment on STENOCARE Expanding in Australia